![]() |
Why Should You …to advance breast cancer research, advocacy, provide access to quality health care… and that’s just the beginning. |
Genome Medicine Publishes Comparative Case Study Worth Reading
Read this article by Baldwin and Cook-Deegan, Constructing narratives of heroism and villainy: case study of Myriad's BRACAnalysis® compared to Genentech's Herceptin®







